- Lobbying
- biogen
Lobbying Arrangements Results for 'Biogen'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Follow-on biologics |
Biogen Idec
|
COVINGTON & BURLING LLP | |||
Details FY 2019 Labor/HHS appropriations bill as it relates to funding for newborn screening. Education about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA. Education about innova... |
Biogen
|
W Strategies, LLC | |||
Details Issues related to treatment of neurological diseases and disorders |
Biogen
|
CLYBURN CONSULTING, LLC | |||
Details Patent Issues, Medicare, Medicaid |
Biogen Idec
Healthcare/Biotechnology |
Tarplin, Downs & Young, LLC | |||
Details Monitor and lobby on healthcare reform legislation |
Biogen Idec
Health Issues |
Capitol Counsel, LLC | |||
Details Monitoring issues relating to pharmaceutical pricing. |
Biogen, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Newborn Screening Quality Assurance Program at CDC; Newborn Screening Implementation Proposal at HRSA. Funding for Newborn Screening Quality Assurance Program at CDC; Newborn Screening Program at H... |
Biogen
|
NVG, LLC | |||
Details Issues related to Medicare Part B and Part D Issues related to the pharmaceutical industry |
Biogen Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan cover... |
BIOGEN
|
in-house lobbying | |||
Details Issues regarding promotion of biosimilars. |
Biogen, Inc.
|
ALSTON & BIRD LLP | |||
Details Legislation that would alter payment policies under Medicare Part B for drugs and biologics. Issues pertaining to Medicare Part D. Biosimilar policies. |
Biogen
|
Thorn Run Partners | |||
Details Patent Reform - S 1145, HR 1908 FDA Globalization Act - HR 3610, S 3409 Follow-on Biologics -- S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act: S 2029 |
BIOGEN IDEC, INC.
|
FOLEY HOAG LLP | |||
Details Issues related to the taxation of the biopharmaceutical industry including international taxation |
The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma
lobbying firm |
DOMER CONSULTING, LLC | |||
Details Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments. Issues dealing with the addition of Spinal Muscular Atrophy to the Recommended Uniform Screening Panel. CMS propos... |
Biogen Inc
|
Capitol Hill Strategies, LLC | |||
Details Alzheimer's Disease. Medicare Reimbursement for Prescription Drugs. Screening and Diagnosis, PET scan coverage and reimbursement and dementia care. Drug pricing and supply chain issues, rare diseas... |
Biogen, Inc.
|
Todd Strategy Group | |||
Details Legislative services related to the House Republican Tax Reform Blueprint, President Trump's Tax Reform Principles, the Senate's Tax Reform Efforts, and the Joint Statement on Tax Reform. |
Biogen Idec, Inc.
|
CAPITOL TAX PARTNERS, LLP | |||
Details Medicare beneficiary access to treatments for Alzheimers disease, including Medicare Part B access issues, including related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. No: 1... |
Biogen, Inc.
|
Capitol Counsel, LLC | |||
Details Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment. Issues related to Alzheimer's Disease and treatment. Issues related to Mental Health tre... |
Biogen, Inc.
|
FEDERAL STREET STRATEGIES, LLC | |||
Details General education about policies impacting pharmaceutical development, approval, and reimbursement; H.R. 1628, American Health Care Act of 2017. Prescription drug user fee agreements and general e... |
Biogen Idec
|
Williams and Jensen, PLLC | |||
Details Health care reform implementation issues; follow on biologics. S. 1417 and H.R. 1281, the Newborn Screening Saves Lives Reauthorization Act of 2013. Health reform implementation issues. Independent... |
BIOGEN IDEC INC.
|
MEHLMAN CASTAGNETTI ROSEN BINGEL & THOMAS, INC. |